researcher comment: the dapa-hf trial | john mcmurray
Published 4 years ago • 1.3K plays • Length 3:30Download video MP4
Download video MP3
Similar videos
-
5:49
researcher comment: the define-hf trial | mikhail kosiborod
-
3:50
dr. mcmurray discusses the dapa-hf trial of dapagliflozin in systolic heart failure
-
1:12
results of dapa-hf - dr. john j mcmurray
-
2:44
dr john mcmurray explains the heart failure benefits of dapagliflozin in diabetics and non-diabetics
-
6:39
expert commentary: the dapa-hf and define-hf trials | lars rydén
-
6:50
new hope for heart failure patients- a gamechanger arrives
-
7:55
diabetes: an inflammatory disease
-
11:19
ehj today - the empa-reg outcome trial
-
21:36
dr. john mcmurray: new and emerging heart failure therapies
-
6:28
emperor-reduced: empagliflozin benefits in hf patients irrespective of diabetes | milton packer
-
5:09
emperor-reduced: time for a change in the hf guidelines? | miles fisher
-
4:40
dr john mcmurray compares emperor-reduced findings with dapa-hf
-
1:22
dr john mcmurray details the preliminary cost-effectiveness distinction of dapagliflozin
-
9:35
preserved-hf: support for dapagliflozin to improve hfpef health status | mikhail kosiborod
-
7:17
researcher comment: the vertis-cv trial | chris cannon
-
7:32
dapa-hf clinical trial i dapagliflozin i hfref
-
5:50
researcher comment: declare-timi 58 | john wilding
-
29:48
professor john mcmurray - heart failure therapy – extending the limits!
-
6:56
dapa hf study results
-
6:57
hfa 2020: dapagliflozin and diuretic use in patients with hfref in dapa-hf — dr alice m jackson
-
1:43
kiersten combs details findings of the dapa-hf study for both diabetic and non-diabetic patients